Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Corcept Therapeutics Inc
SWB:HTD
Corcept Therapeutics Inc
SWB:HTD
Price:
80.64
EUR
-1.9%
Market Closed
Market Cap:
€5.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
C
|
Coca-Cola Femsa SAB de CV
SWB:CFSL
|
MX |
|
C
|
Coca-Cola Co
SWB:CCC3
|
US |
|
A
|
AT&T Inc
XMUN:SOBA
|
US |
|
K
|
KGHM Polska Miedz SA
XMUN:KGHA
|
PL |
|
P
|
Planet Fitness Inc
F:3PL
|
US |
|
S
|
Sherwin-Williams Co
F:SJ3
|
US |
|
A
|
Alibaba Group Holding Ltd
F:AHLA
|
HK |
Wall St Price Targets
HTD Price Forecast
Based on 7 analysts
Based on 7 analysts
+76% Upside
from
€80.64
today
Corcept Therapeutics Inc (HTD)’s 12-month stock price forecast through July 2027 has a consensus target of €142.05, implying 76% upside. The forecast is based on price targets from 7 Wall Street analysts.
HTD Analyst Rating
No ratings yet
No ratings yet
Corcept Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
142.05
EUR
142.05
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 142.05 EUR with a low forecast of 43.28 EUR and a high forecast of 148.47 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
158%
158%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 158%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.